Related Experiment Video
Updated: May 13, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Significant decrease in plasma midregional proadrenomedullin level in patients with end-stage renal disease after
Yosuke Suzuki1, Hiroki Itoh, Fumihiko Katagiri
1Department of Clinical Pharmacy, Oita University Hospital, Hasama-machi, Oita 879-5593, Japan. y-suzuki@oita-u.ac.jp
Abstract:
Impaired renal function has been suggested to significantly impact plasma midregional proADM (MR-proADM) level. The aim of this study was to assess whether improvement of renal function after living kidney transplantation has an impact on plasma MR-proADM-like immunoreactive substance (IS) level. Eleven patients with end-stage renal disease (ESRD) who were scheduled to undergo the first living kidney allograft transplantation were enrolled. Plasma MR-proADM-IS levels were measured before and 3, 7, 10, 14, 21, 30, 60 and 90 days after kidney transplantation. Plasma MR-proADM-IS level decreased significantly from day 3 after kidney transplantation compared to before kidney transplantation. A significant negative correlation was observed between creatinine clearance and plasma MR-proADM-IS level from before to 90 days after kidney transplantation (rs=-0.70, p<0.0001). These results suggest that recovery of kidney function after kidney transplantation may lead to decrease in plasma MR-proADM level in patients with ESRD, and that plasma MR-proADM level may depend largely on renal function.
Insights
Kidney function significantly impacts midregional pro-adrenomedullin (MR-proADM) levels. Successful kidney transplantation in end-stage renal disease patients led to a notable decrease in MR-proADM, suggesting renal function influences this biomarker.
Area of Science:
- Nephrology
- Biomarkers
- Transplantation Immunology
Background:
- Impaired renal function is associated with elevated plasma midregional pro-adrenomedullin (MR-proADM) levels.
- MR-proADM is a biomarker potentially influenced by kidney function.
Purpose of the Study:
- To investigate the effect of improved renal function post-living kidney transplantation on plasma MR-proADM levels.
- To determine the relationship between renal function recovery and MR-proADM concentration.
Main Methods:
- Prospective study involving 11 end-stage renal disease patients undergoing living kidney transplantation.
- Serial measurement of plasma MR-proADM-like immunoreactive substance (IS) before and up to 90 days after transplantation.
- Correlation analysis between MR-proADM-IS levels and creatinine clearance.
Main Results:
- Plasma MR-proADM-IS levels significantly decreased starting from day 3 post-transplantation compared to pre-transplant levels.
- A strong negative correlation (rs=-0.70, p<0.0001) was found between creatinine clearance and plasma MR-proADM-IS.
- These findings indicate a direct relationship between kidney function and MR-proADM levels.
Conclusions:
- Recovery of renal function following kidney transplantation leads to a reduction in plasma MR-proADM levels in ESRD patients.
- Plasma MR-proADM levels are significantly dependent on renal function.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
